Novavax to Host Conference Call to Discuss First Quarter Financial Results on May 7, 2015
April 30 2015 - 4:06PM
GAITHERSBURG, Md., April 30, 2015 (GLOBE NEWSWIRE)
-- Novavax, Inc., (Nasdaq:NVAX) a clinical-stage vaccine company
focused on the discovery, development and commercialization of
recombinant nanoparticle vaccines and adjuvants, today announced it
will report its first quarter 2015 financial and operating results
after the close of U.S. financial markets on Thursday, May 7,
2015.
In addition, management will host a conference
call to discuss the quarterly results and provide an update on
corporate activities.
Conference call details are as follows: |
Date: |
May 7,
2015 |
Time: |
4:30 pm US
Eastern Time |
Dial-in
number: |
(877)
212-6076 (Domestic) or (707) 287-9331 (International) |
Via
web: |
www.novavax.com, "Investor Info"/"Events" |
|
|
Conference call replay: |
Dates: |
Starting at
7:30 pm ET on May 7, 2015 until midnight May 14, 2015 |
Dial-in
number: |
(855)
859-2056 (Domestic) or (404) 537-3406 (International) |
Passcode: |
35660022 |
Via
web: |
www.novavax.com, "Investor Info"/"Events" |
About
Novavax
Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage
vaccine company committed to delivering novel products to prevent a
broad range of infectious diseases. Its recombinant nanoparticles
and Matrix-M(TM) adjuvant technology are the foundation for
ground-breaking innovation that improves global health through safe
and effective vaccines. Additional information about Novavax is
available on the company's website, www.novavax.com.
CONTACT: Novavax, Inc.
Barclay A. Phillips
SVP, Chief Financial Officer and Treasurer
Andrea N. Flynn, Ph.D.
Senior Manager, Investor Relations
ir@novavax.com
240-268-2000
Russo Partners, LLC
David Schull
Todd Davenport, Ph.D.
david.schull@russopartnersllc.com
todd.davenport@russopartnersllc.com
212-845-4271
This
announcement is distributed by NASDAQ OMX Corporate Solutions on
behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Novavax, Inc. via Globenewswire
HUG#1917366
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Apr 2023 to Apr 2024